
    
      A multicenter, open, prospective, Phase IV study of Ciclopirox olamine on patients from 3
      months to 10 years with all kinds of dermatomycoses. All body areas were treatable except
      scalp and nails (no tinea on the scalp nor onychomycoses) . Cream applied BID between 6.00
      and 10.00am and 7.00 and 10.00pm daily for 4 weeks.Control visit after 4 more weeks without
      treatment was performed in order to evaluate the relapse rate.
    
  